These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6086949)

  • 41. Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses.
    Dewindt B; van Eemeren K; Andries K
    Antiviral Res; 1994 Sep; 25(1):67-72. PubMed ID: 7811059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells.
    Reischl A; Reithmayer M; Winsauer G; Moser R; Gösler I; Blaas D
    J Virol; 2001 Oct; 75(19):9312-9. PubMed ID: 11533194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and folding of human very-low-density lipoprotein receptor fragments: neutralization capacity toward human rhinovirus HRV2.
    Ronacher B; Marlovits TC; Moser R; Blaas D
    Virology; 2000 Dec; 278(2):541-50. PubMed ID: 11118376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.
    Greve JM; Forte CP; Marlor CW; Meyer AM; Hoover-Litty H; Wunderlich D; McClelland A
    J Virol; 1991 Nov; 65(11):6015-23. PubMed ID: 1681115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules.
    Martin S; Casasnovas JM; Staunton DE; Springer TA
    J Virol; 1993 Jun; 67(6):3561-8. PubMed ID: 8098781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Picornaviral gene order: comparison of a rhinovirus with a cardiovirus.
    McLean C; Rueckert RR
    J Virol; 1973 Feb; 11(2):341-4. PubMed ID: 4347432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reproducible plaquing system for rhinovirus serotypes in HeLa cells--agarose suspension.
    Sethi SK
    Acta Virol; 1978 Jan; 22(1):60-5. PubMed ID: 25009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct cellular receptor interactions in poliovirus and rhinoviruses.
    Xing L; Tjarnlund K; Lindqvist B; Kaplan GG; Feigelstock D; Cheng RH; Casasnovas JM
    EMBO J; 2000 Mar; 19(6):1207-16. PubMed ID: 10716921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An optical thin film assay incorporating rhinovirus protease inhibitors as detector reagents.
    Ettinger A; Ostroff R; Rhihanek M; Dragovich PS; Zalman LS; Patick AK; Prins TJ; Fuhrman SA; Brown EL; Worland ST; Polisky B
    Antiviral Res; 2004 Mar; 61(3):153-9. PubMed ID: 15168795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.
    Staunton DE; Gaur A; Chan PY; Springer TA
    J Immunol; 1992 May; 148(10):3271-4. PubMed ID: 1349619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination.
    Vlasak M; Blomqvist S; Hovi T; Hewat E; Blaas D
    J Virol; 2003 Jun; 77(12):6923-30. PubMed ID: 12768011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Avian homologs of the mammalian low-density lipoprotein receptor family bind minor receptor group human rhinovirus.
    Gruenberger M; Wandl R; Nimpf J; Hiesberger T; Schneider WJ; Kuechler E; Blaas D
    J Virol; 1995 Nov; 69(11):7244-7. PubMed ID: 7474146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a YAC-1 mouse cell receptor for group B coxsackieviruses.
    Hsu KH; Crowell RL
    J Virol; 1989 Jul; 63(7):3105-8. PubMed ID: 2724420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rhinoviruses.
    Stott EJ; Killington RA
    Annu Rev Microbiol; 1972; 26():503-24. PubMed ID: 4343002
    [No Abstract]   [Full Text] [Related]  

  • 55. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
    Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
    J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of R 61837, a new antirhinovirus compound.
    Andries K; Dewindt B; De Brabander M; Stokbroekx R; Janssen PA
    Arch Virol; 1988; 101(3-4):155-67. PubMed ID: 2845889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of serotype specificity and protein structure of the five U.S. serotypes of bluetongue virus.
    Mecham JO; Dean VC; Jochim MM
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2617-24. PubMed ID: 2432162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.
    Hoover-Litty H; Greve JM
    J Virol; 1993 Jan; 67(1):390-7. PubMed ID: 8093221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystallization of human rhinovirus 1A.
    Korant BD; Stasny JT
    Virology; 1973 Oct; 55(2):410-7. PubMed ID: 4355113
    [No Abstract]   [Full Text] [Related]  

  • 60. Evidence for the role of the P2 protein of human rhinovirus in its host range change.
    Lomax NB; Yin FH
    J Virol; 1989 May; 63(5):2396-9. PubMed ID: 2539529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.